$1.49
+0.06 (+4.20%)
Open$1.42
Previous Close$1.43
Day High$1.55
Day Low$1.40
52W High$3.27
52W Low$0.97
Volume—
Avg Volume207.1K
Market Cap33.03M
P/E Ratio—
EPS$-7.37
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,392.6% upside
Current
$1.49
$1.49
Target
$22.24
$22.24
$15.33
$22.24 avg
$34.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.23M | 4.81M | 4.77M |
| Net Income | -2,377,341,856 | 633.7K | 796.1K |
| Profit Margin | -73,682.7% | 13.2% | 16.7% |
| EBITDA | -2,384,450,733 | 1.15M | 1.15M |
| Free Cash Flow | — | 870.8K | 772.5K |
| Rev Growth | — | +22.7% | +21.0% |
| Debt/Equity | — | 0.81 | 0.64 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |